BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 33623948)

  • 1. Comparison of cubosomes and liposomes for the encapsulation and delivery of curcumin.
    Chang C; Meikle TG; Drummond CJ; Yang Y; Conn CE
    Soft Matter; 2021 Mar; 17(12):3306-3313. PubMed ID: 33623948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic study of the effect of lipid architecture on cytotoxicity and cellular uptake of cationic cubosomes.
    Pushpa Ragini S; Dyett BP; Sarkar S; Zhai J; White JF; Banerjee R; Drummond CJ; Conn CE
    J Colloid Interface Sci; 2024 Jun; 663():82-93. PubMed ID: 38394820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
    Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
    Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells.
    Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M
    J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: ex vivo permeation and in vivo pharmacokinetic studies.
    Salah S; Mahmoud AA; Kamel AO
    Drug Deliv; 2017 Nov; 24(1):846-856. PubMed ID: 28535740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, optimization and characterization of cisplatin loaded cubosomes for human lung carcinoma.
    Umar H; Wahab HA; Ahmed N; Fujimura NA; Amjad MW; Bukhari SNA; Ahmad W
    Drug Dev Ind Pharm; 2024 Mar; ():1-14. PubMed ID: 38451066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin Encapsulated in Crosslinked Cyclodextrin Nanoparticles Enables Immediate Inhibition of Cell Growth and Efficient Killing of Cancer Cells.
    Möller K; Macaulay B; Bein T
    Nanomaterials (Basel); 2021 Feb; 11(2):. PubMed ID: 33672006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous Microfluidic Production of Citrem-Phosphatidylcholine Nano-Self-Assemblies for Thymoquinone Delivery.
    Ilhan-Ayisigi E; Ghazal A; Sartori B; Dimaki M; Svendsen WE; Yesil-Celiktas O; Yaghmur A
    Nanomaterials (Basel); 2021 Jun; 11(6):. PubMed ID: 34200457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Insight into Cubosomal Drug Delivery Approaches: An Explicative Review.
    Mukherjee S; Dutta A; Ash D; Karati D
    Pharm Nanotechnol; 2024 Jun; ():. PubMed ID: 38910488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Dynamics and In Vitro Studies Elucidating the Tunable Features of Reconfigurable Nanodiscs for Guiding the Optimal Design of Curcumin Formulation.
    Li Y; Xu W; Wang X; Lai R; Qiu X; Zeng Z; Wang Z; Wang J
    Bioengineering (Basel); 2024 Feb; 11(3):. PubMed ID: 38534519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared Genetic and Epigenetic Mechanisms between the Osteogenic Differentiation of Dental Pulp Stem Cells and Bone Marrow Stem Cells.
    Gaus S; Li H; Li S; Wang Q; Kottek T; Hahnel S; Liu X; Deng Y; Ziebolz D; Haak R; Schmalz G; Liu L; Savkovic V; Lethaus B
    Biomed Res Int; 2021; 2021():6697810. PubMed ID: 33628811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes to Cubosomes: The Evolution of Lipidic Nanocarriers and Their Cutting-Edge Biomedical Applications.
    Attri N; Das S; Banerjee J; Shamsuddin SH; Dash SK; Pramanik A
    ACS Appl Bio Mater; 2024 May; 7(5):2677-2694. PubMed ID: 38613498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cubosomes as versatile lipid nanocarriers for neurological disorder therapeutics: a comprehensive review.
    A Vahab S; Nair A; Raj D; G P A; P P S; S Kumar V
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3729-3746. PubMed ID: 38095651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy.
    Singh S; Sachan K; Verma S; Singh N; Singh PK
    Curr Pharm Biotechnol; 2024; 25(6):757-771. PubMed ID: 37929730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A microfluidic platform for the controlled synthesis of architecturally complex liquid crystalline nanoparticles.
    Pilkington CP; Contini C; Barritt JD; Simpson PA; Seddon JM; Elani Y
    Sci Rep; 2023 Aug; 13(1):12684. PubMed ID: 37542147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nanotech Potential of Curcumin in Pharmaceuticals: An Overview.
    Pardeshi S; Mohite P; Rajput T; Puri A
    Curr Drug Discov Technol; 2024; 21(2):e260723219113. PubMed ID: 37493163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in the Development of Liquid Crystalline Nanoparticles as Drug Delivery Systems.
    Leu JSL; Teoh JJX; Ling ALQ; Chong J; Loo YS; Mat Azmi ID; Zahid NI; Bose RJC; Madheswaran T
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications.
    Akombaetwa N; Ilangala AB; Thom L; Memvanga PB; Witika BA; Buya AB
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839978
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.